The Role of Peroxiredoxin Family in Cancer Signaling
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Yosup | - |
dc.contributor.author | Jang, Ho Hee | - |
dc.date.available | 2020-02-27T03:40:54Z | - |
dc.date.created | 2020-02-04 | - |
dc.date.issued | 2019-06 | - |
dc.identifier.issn | 2288-3649 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/1454 | - |
dc.description.abstract | Peroxiredoxins (Prxs) are antioxidant enzymes that protect cells from oxidative stress by reducing intracellular accumulation of reactive oxygen species (ROS). In mammalian cells, the six Prx isoforms are ubiquitously expressed in diverse intracellular locations. They are involved in the regulation of various physiological processes including cell growth, differentiation, apoptosis, immune response and metabolism as well as intracellular ROS homeostasis. Although there are increasing evidences that Prxs are involved in carcinogenesis of many cancers, their role in cancer is controversial. The ROS levels in cancer cells are increased compared to normal cells, thus promoting cancer development. Nevertheless, for various cancer types, an overexpression of Prxs has been found to be associated with poor patient prognosis, and an increasing number of studies have reported that tumorigenesis is either facilitated or inhibited by regulation of cancer-associated signaling pathways. This review summarizes Prx isoforms and their basic functions, the relationship between the expression level and the physiological role of Prxs in cancer cells, and their roles in regulating cancer-associated signaling pathways. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | KOREAN SOC CANCER PREVENTION | - |
dc.relation.isPartOf | JOURNAL OF CANCER PREVENTION | - |
dc.title | The Role of Peroxiredoxin Family in Cancer Signaling | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 2 | - |
dc.identifier.wosid | 000477679600001 | - |
dc.identifier.doi | 10.15430/JCP.2019.24.2.65 | - |
dc.identifier.bibliographicCitation | JOURNAL OF CANCER PREVENTION, v.24, no.2, pp.65 - 71 | - |
dc.identifier.kciid | ART002484784 | - |
dc.description.isOpenAccess | N | - |
dc.citation.endPage | 71 | - |
dc.citation.startPage | 65 | - |
dc.citation.title | JOURNAL OF CANCER PREVENTION | - |
dc.citation.volume | 24 | - |
dc.citation.number | 2 | - |
dc.contributor.affiliatedAuthor | Kim, Yosup | - |
dc.contributor.affiliatedAuthor | Jang, Ho Hee | - |
dc.type.docType | Review | - |
dc.subject.keywordAuthor | Peroxiredoxins | - |
dc.subject.keywordAuthor | Oxidative stress | - |
dc.subject.keywordAuthor | Cancer | - |
dc.subject.keywordAuthor | Peroxidase activity | - |
dc.subject.keywordAuthor | Tumorigenesis | - |
dc.subject.keywordPlus | HUMAN LUNG-CANCER | - |
dc.subject.keywordPlus | OXIDATIVE STRESS | - |
dc.subject.keywordPlus | PROSTATE-CANCER | - |
dc.subject.keywordPlus | ANTIOXIDANT DEFENSE | - |
dc.subject.keywordPlus | CELL-PROLIFERATION | - |
dc.subject.keywordPlus | ANDROGEN RECEPTOR | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordPlus | MECHANISMS | - |
dc.subject.keywordPlus | SULFIREDOXIN | - |
dc.subject.keywordPlus | PROGRESSION | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.